Theranostics 2022; 12(8):3607. doi:10.7150/thno.73098 This issue

Erratum

Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum

Feng Zhang1,3,4, Shuai Lu5, Jianlin He2, Huanhuan Jin1, Feixia Wang1, Li Wu1,3,4, Jiangjuan Shao3,4, Anping Chen6, Shizhong Zheng1,3,4 Corresponding address

1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
2. Third Institute of Oceanography, State Oceanic Administration, Xiamen 361005, China.
3. Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
4. State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
5. School of Science, China Pharmaceutical University, Nanjing 211198, China.
6. Department of Pathology, School of Medicine, Saint Louis University, MO 63104, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α: Erratum. Theranostics 2022; 12(8):3607. doi:10.7150/thno.73098. Available from https://www.thno.org/v12p3607.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 610

 

The authors regret that the original version of this paper unfortunately contained an inappropriate representative image of Boyden chamber assay. An inappropriate image was inadvertently used for the HSC-LX2 Ligu+GW9662 (Figure 4F) during the assembly of this figure. The authors confirm that the correction of Figure 4F does not affect the original conclusions. The authors sincerely apologize for any inconvenience or misunderstanding that the error may have caused. The corrected image is shown below.

 Figure 1 

Corrected image for original Figure 4F.

Theranostics Image

(View in new window)

Author contact

Corresponding address Corresponding author: Dr Shizhong Zheng, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, Jiangsu, China. Tel: 86-025-85811246; Email: 300631edu.cn, nytwscom


Published 2022-4-26